Scor SE
SIX:SCR

Watchlist Manager
Scor SE Logo
Scor SE
SIX:SCR
Watchlist
Price: 23.22 CHF 1.62% Market Closed
Market Cap: CHf4.2B

Scor SE
Investor Relations

Amid the labyrinth of the global reinsurance industry, Scor SE stands resolute, carving a niche with its astute risk assessment and management capabilities. Headquartered in Paris, this formidable player in the reinsurance arena operates through two primary segments: life reinsurance and property and casualty reinsurance. Scor SE’s prowess lies in its ability to forecast and evaluate risks faced by insurance companies globally, leveraging world-class actuarial expertise and cutting-edge analytical tools. By assuming a portion of risks underwritten by its clients—primary insurers—Scor SE enables these companies to preserve capital, manage volatility, and comply with regulatory demands. This symbiotic relationship allows Scor SE to charge premiums for taking on these risks, which forms the bedrock of its revenue stream.

In addition to the premiums collected, Scor SE amplifies its financial muscle through sound investment strategies, harnessing the returns from its vast financial reserves. The company's focus on diversification ensures that it remains resilient amid ever-present market fluxes and natural catastrophes. This investment income becomes particularly crucial in balancing the underwriting losses that can occur in an unpredictable global climate. With a consistent emphasis on innovation, Scor SE utilizes sophisticated risk modeling and data analytics, positioning itself as a dynamic leader committed to delivering value through prudent risk management and wealth creation strategies for stakeholders worldwide.

Show more
Loading
SCR
Swiss Market Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Mar 4, 2026
AI Summary
Q4 2025

Profit: SCOR reported a record full-year net income of EUR 846 million and Q4 net income of EUR 214 million (Q4 implying an annualized ROE of 21.1%).

Capital position: Group solvency ratio finished at 215% (up 5 points vs 2024) and management proposes a dividend of EUR 1.9 per share (up 5.6%).

Underwriting: P&C delivered strong underwriting with an attritional loss ratio of 74.7% in Q4 (76.4% YTD) and management expects a P&C combined ratio below 87% in 2026.

Life & Health: Life new business CSM was EUR 170 million in Q4 and EUR 464 million for the full year; Life insurance service result was EUR 115 million in Q4 and EUR 450 million for the year (above the ~EUR 0.4 billion target).

Capital generation outlook: After a better-than-expected 2025, management expects net-net operating capital generation of 3 to 5 percentage points of solvency ratio in 2026.

Operational efficiency & strategy: EUR 170 million of savings delivered (one year ahead of target); progress on ALM, AI projects and risk-partnership expansion highlighted.

Other items: Economic value up 13.7% at constant economics; return on invested assets 3.6% in Q4 with investment income EUR 209 million; arbitration decision expected mid-2026.

Key Financials
Net income (full year)
EUR 846 million
Net income (Q4)
EUR 214 million
Return on equity (full year)
19.1%
Return on equity (Q4 annualized)
21.1%
Solvency ratio
215%
Proposed dividend per share
EUR 1.9
Economic value growth
13.7% at constant economics (full year)
Economic value per share
EUR 48
Savings delivered
EUR 170 million
P&C nat cat ratio (Q4)
7.6%
P&C nat cat ratio (YTD)
6.8%
P&C attritional loss ratio (Q4)
74.7%
P&C attritional loss ratio (YTD)
76.4%
P&C combined ratio target
below 87% (Forward '26 assumption)
Life & Health new business CSM (Q4)
EUR 170 million
Life & Health new business CSM (full year)
EUR 464 million
Life & Health CSM (stock)
EUR 4.9 billion
Life & Health insurance service result (Q4)
EUR 115 million
Life & Health insurance service result (full year)
EUR 450 million
Return on invested assets (Q4)
3.6%
Investment income (Q4)
EUR 209 million
Regular income yield (investments)
3.8%
Financial leverage
25.3%
Tier 2 remaining call amount
EUR 283 million (first call date 8 June 2026)
Economic value growth target (Forward '26)
9% per annum (plan target)
Group effective tax rate (full year 2025)
28%
Group expense ratio (2025)
7.4% (full year)
Net-net operating capital generation (2026 expectation)
3 to 5 percentage points of solvency ratio
Arbitration timeline
Decision expected mid-2026 / by summer 2026
Call option strike and expiry
EUR 28 strike; option expires in June 2026
Earnings Call Recording
Other Earnings Calls

Management

Mr. Thierry Leger
CEO & Director
No Bio Available
Dr. Francois de Varenne Ph.D.
Group CFO & Deputy CEO
No Bio Available
Ms. Claire Le Gall-Robinson
Group Company Secretary & Group Chief ESG
No Bio Available
Mr. Fabian Peder Gultier Uffer
Group Chief Risk Officer
No Bio Available
Mr. Redmond Murphy
Deputy CEO of SCOR Life & Health
No Bio Available
Mr. Jean-Paul Conoscente-Jacopin
Chief Executive Officer of SCOR Property & Casualty
No Bio Available
Ms. Claudia Dill M.B.A.
Group Chief Operating Officer
No Bio Available
Mr. Marc Philippe
Chief Information Officer
No Bio Available
Mr. Thomas Fossard
Head of Investor Relations
No Bio Available
Mr. Spencer Alridge
Group Chief Compliance Officer
No Bio Available

Contacts

Address
ILE-DE-FRANCE
Paris
5 Avenue Kleber
Contacts
+33158447000.0
www.scor.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett